LaSalle St. Investment Advisors, LLC

Position in HUMA — Humacyte, Inc.

CIK 1966193 ELMHURST, IL

Position in HUMA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$88,817

+$46,544 QoQ

Shares Held

113,869

+63.5% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#48

of 161 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LaSalle St. Investment Advisors, LLC holds $420,547 across 4 Biotechnology names. HUMA ranks #2 (21.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RXRX	Recursion Pharmaceuticals, Inc.	68,000	$249,560
2	HUMA	Humacyte, Inc. This page	113,869	$88,817
3	SANA	Sana Biotechnology, Inc.	22,000	$76,780
4	GTBP	GT Biopharma, Inc.	11,000	$5,390

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$88,817	113,869	+63.5%	Shares	Sole	2026-08-11
2026-03-31	$42,273	69,644	+1.1%	Shares	Sole	2026-05-08
2025-12-31	$66,228	68,916	+2.4%	Shares	Sole	2026-02-17
2025-09-30	$117,129	67,316	+11.3%	Shares	Sole	2025-11-13
2025-06-30	$126,430	60,493	+43.0%	Shares	Sole	2025-08-14
2025-03-31	$72,119	42,299	—	Shares	Sole	2025-05-12
No filing history on record for this holder in this stock.